Latest Medical research News

Indiana State graduate's $250K gift to create cancer center

Sep. 26, 2020 9:51 AM EDT

TERRE HAUTE, Ind. (AP) — An Indiana State University graduate who went on to a decades-long career in manufacturing has donated $250,000 to the western Indiana school for the creation of a new cancer research center. School officials said the gift from Rich Porter and his wife, Robin, will provide a...

An employee of SinoVac works in a lab at a factory producing its SARS CoV-2 Vaccine for COVID-19 named CoronaVac in Beijing on Thursday, Sept. 24, 2020. SinoVac's CEO says they have injected 90 percent of its employees and family members, or about 3,000 people, and provided tens of thousands of rounds of CoronaVac to the municipal government of Beijing. It's a highly unusual move that raises ethical and safety questions, as companies and governments worldwide race to develop a vaccine that will stop the spread of the new coronavirus. (AP Photo/Ng Han Guan)

China pushes emergency use of COVID vaccine despite concerns

Sep. 26, 2020 6:58 AM EDT

BEIJING (AP) — After the first shot, he had no reaction. But Kan Chai felt woozy following the second dose of a COVID-19 vaccine approved for emergency use in China. “When I was driving on the road, I suddenly felt a bit dizzy, as if I was driving drunk," the popular writer and columnist recounted...

FILE - In this July 22, 2020, file photo, Tyson Salomon, left, gets a pedicure outside Pampered Hands nail salon in Los Angeles. A steady drop in coronavirus cases across California cleared the way Tuesday, Sept. 22, 2020, for the wider reopening of businesses in nine counties, including much of the San Francisco Bay Area, the state's top health official said. Dr. Mark Ghaly, the state health secretary, said nail salons could also reopen with restrictions, though he cautioned that California's reopening must remain

The Latest: Concerns over coronavirus upticks in California

Sep. 25, 2020 9:38 PM EDT

SACRAMENTO, Calif. -- California has begun to see concerning upticks in coronavirus data after a period of decline. The state health secretary said Friday that there have been increases in the number of newly confirmed cases, hospital emergency department visits for COVID-19 and new hospitalizations for...

Minnesota halts COVID-19 study after reports of intimidation

Sep. 25, 2020 2:29 PM EDT

MINNEAPOLIS (AP) — Minnesota officials have stopped a COVID-19 testing study after multiple reports that state and federal public health workers were greeted by racial and ethnic slurs as they went door-to-door. The U.S. Centers for Disease Control and Prevention pulled federal surveyors out of Minnesota...

FILE - In this Monday, March 4, 2019 file photo, Timothy Ray Brown poses for a portrait in Seattle.  Brown, an American who was known for years as the Berlin patient, had a transplant in Germany from a donor with natural resistance to the AIDS virus. It was thought to have cured Brown's leukemia and HIV. But in an interview Thursday, Sept. 24, 2020, Brown said his cancer returned last year and has spread widely. His case has inspired scientists to seek more practical ways to try to cure the disease.  (AP Photo/Manuel Valdes)

First man cured of HIV infection now has terminal cancer

Sep. 25, 2020 9:49 AM EDT

Timothy Ray Brown, the first person known to have been cured of HIV infection, says he is now terminally ill from a recurrence of the cancer that prompted his historic treatment 12 years ago. Brown, dubbed “the Berlin patient” because of where he lived at the time, had a transplant from a donor with...

People board a bus outside Waterloo station in London, Wednesday, Sept. 23, 2020, after Prime Minister Boris Johnson announced a range of new restrictions to combat the rise in coronavirus cases in England, Wednesday, Sept. 23, 2020. (Dominic Lipinski/PA via AP)

Drugmaker Novavax begins late-stage vaccine trial in UK

Sep. 25, 2020 8:38 AM EDT

LONDON (AP) — U.S.-based Novavax has begun a late stage trial of its potential COVID-19 vaccine in the United Kingdom because the high-level of the coronavirus circulating in the country is likely to produce quick results, the pharmaceutical company said. Novavax plans to test the effectiveness of its...

Flower vendors wait for buyers at a wholesale market in Bengaluru, India, Thursday, Sept. 24, 2020. The nation of 1.3 billion people is expected to become the COVID-19 pandemic's worst-hit country within weeks, surpassing the United States. (AP Photo/Aijaz Rahi)

The Latest: $14M more in virus funds for 3 Ariz universities

Sep. 24, 2020 9:23 PM EDT

PHOENIX — Arizona will provide the state’s three public universities with $14 million in additional funding to boost their efforts to test, track and respond to the coronavirus. Gov. Doug Ducey said Thursday the money will help the universities build on their current efforts to track and contain...

Yin Weidong, CEO of the Chinese pharmaceutical company SinoVac, speaks to journalists during a tour of a vaccine factory in Beijing on Thursday, Sept. 24, 2020. SinoVac, one of China's pharmaceutical companies behind a leading COVID-19 vaccine candidate says its vaccine will be ready by early 2021 for distribution worldwide, including the U.S. (AP Photo/Ng Han Guan)

Chinese company says coronavirus vaccine ready by early 2021

Sep. 24, 2020 9:15 PM EDT

BEIJING (AP) — A Chinese pharmaceutical company said Thursday the coronavirus vaccine it is developing should be ready by early 2021 for distribution worldwide, including the United States. Yin Weidong, the CEO of SinoVac, vowed to apply to the U.S. Food and Drug Administration to sell CoronaVac in the...

Houston sampling wastewater to track spread of COVID-19

Sep. 24, 2020 7:57 PM EDT

HOUSTON (AP) — Results from a program that’s testing Houston’s wastewater to monitor the local spread of the coronavirus have shown that it could be a faster way of detecting outbreaks in the nation’s fourth-largest city, officials said Thursday. Since May, the city and scientists from...

FILE - In this Wednesday, Aug. 5, 2020 file photo, senior Clinical Research Nurse Ajithkumar Sukumaran prepares the COVID 19 vaccine to administer to a volunteer, at a clinic in London. The British government on Thursday, Sept. 24, 2020 says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine works. The approach, called a challenge study, is risky but proponents think it may produce results faster than typical studies, which wait to see if volunteers who have been given an experimental treatment or a dummy version get sick.  (AP Photo/Kirsty Wigglesworth, File)

UK may take part in COVID-19 vaccine 'challenge studies'

Sep. 24, 2020 4:37 PM EDT

LONDON (AP) — The British government says it may take part in a study that tries to deliberately infect volunteers who have been given an experimental vaccine against the coronavirus in an effort to more quickly determine if the vaccine works. The approach, called a challenge study, is risky but...